The Mexican consensus on nonalcoholic fatty liver disease

被引：41

作者：

Bernal-Reyes, R. ^{[1
]}

Castro-Narro, G. ^{[2
]}

Male-Velazquez, R. ^{[3
]}

Carmona-Sanchez, R. ^{[4
]}

Gonzalez-Huezo, M. S. ^{[5
]}

Garcia-Juarez, I. ^{[2
]}

Chavez-Tapia, N. ^{[6
]}

Aguilar-Salinas, C. ^{[7
]}

Aiza-Haddad, I. ^{[8
]}

Ballesteros-Amozurrutia, M. A. ^{[9
]}

Bosques-Padilla, F. ^{[10
]}

Castillo-Barradas, M. ^{[11
]}

Chavez-Barrera, J. A. ^{[12
]}

Cisneros-Garza, L. ^{[13
]}

Flores-Calderon, J. ^{[14
]}

Garcia-Compean, D. ^{[13
]}

Gutierrez-Grobe, Y. ^{[6
]}

Higuera de la Tijera, M. F. ^{[15
]}

Kershenobich-Stalnikowitz, D. ^{[7
]}

Ladron de Guevara-Cetina, L. ^{[16
]}

Lizardi-Cervera, J. ^{[6
]}

Lopez-Cossio, J. A. ^{[5
]}

Martinez-Vazquez, S. ^{[2
]}

Marquez-Guillen, E. ^{[7
]}

Mendez-Sanchez, N. ^{[6
]}

Moreno-Alcantar, R. ^{[17
]}

Poo-Ramirez, J. L. ^{[18
]}

Ramos-Martinez, P. ^{[19
]}

Rodriguez-Hernandez, H. ^{[20
]}

Sanchez-Avila, J. F. ^{[21
]}

Stoopen-Rometti, M. ^{[22
]}

Torre-Delgadillo, A. ^{[2
]}

Torres-Villalobos, G. ^{[7
]}

Trejo-Estrada, R. ^{[23
]}

Uribe-Esquivel, M. ^{[6
]}

Velarde-Ruiz Valazco, J. A. ^{[24
]}

机构：

[1] Soc Espanola Beneficencia, Pachuca, Hidalgo, Mexico

[2] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Gastroenterol, Mexico City, DF, Mexico

[3] Inst Salud Digest & Hepat SA CV, Guadalajara, Jalisco, Mexico

[4] Consulta Privada, San Luis Potosi, Mexico

[5] ISSSEMYM, Serv Gastroenterol & Endoscopia GI, Metepec, Estado De Mexic, Mexico

[6] Fdn Clin Med Sur, Serv Gastroenterol, Mexico City, DF, Mexico

[7] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Mexico City, DF, Mexico

[8] Hosp Angeles Lomas, Clin Enfermedades Hepat, Mexico City, DF, Mexico

[9] Hosp Angeles Pedregal, Mexico City, DF, Mexico

[10] Ctr Med Zambrano Hell, Monterrey, Nuevo Leon, Mexico

[11] Hosp Especialidades Ctr Med La Raza, Ctr Med La Raza IMSS, Serv Gastroenterol, Mexico City, DF, Mexico

[12] IMSS, Ctr Med La Raza, Serv Gastroenterol Pediat, Hosp Gen, Mexico City, DF, Mexico

[13] Hosp Univ UANL, Serv Gastroenterol, Monterrey, Nuevo Leon, Mexico

[14] IMSS, Ctr Med Siglo 21, Hosp Pediat, Serv Gastroenterol, Mexico City, DF, Mexico

[15] Hosp Gen Mexico City, Serv Gastroenterol, Mexico City, DF, Mexico

[16] Hosp Angeles Clin Londres, Mexico City, DF, Mexico

[17] Hosp Especialidades Ctr Med La Raza, Ctr Med Siglo 21, IMSS, Serv Gastroenterol, Mexico City, DF, Mexico

[18] Tec Monterrey, Ctr Innovac & Educ Ejecut, Mexico City, DF, Mexico

[19] Ctr Patol Especializada SLP, San Luis Potosi, Mexico

[20] Hosp Especialidades Ctr Med La Raza, United Invest Biomed AMCCI, Durango, Mexico

[21] Tecnol Monterrey, Escuela Med & Ciencias Salud, Monterrey, Nuevo Leon, Mexico

[22] Ctr Diagnost CT Scanner Lomas Altas, Mexico City, DF, Mexico

[23] Ctr Med ABC, Mexico City, DF, Mexico

[24] Hosp Civil Guadalajara, Dept Gastroenterol, Guadalajara, Jalisco, Mexico

来源：

REVISTA DE GASTROENTEROLOGIA DE MEXICO | 2019年 / 84卷 / 01期

关键词：

Nonalcoholic fatty liver disease; Mexican consensus; CONTROLLED TRANSIENT ELASTOGRAPHY; INTRAHEPATIC LIPID-CONTENT; PLACEBO-CONTROLLED TRIAL; MAGNETIC-RESONANCE ELASTOGRAPHY; HEPATOCELLULAR-CARCINOMA HCC; DE-NOVO LIPOGENESIS; LONG-TERM OUTCOMES; VITAMIN-E; CRYPTOGENIC CIRRHOSIS; INSULIN-RESISTANCE;

D O I：

10.1016/j.rgmx.2018.11.007

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Nonalcoholic fatty liver disease (NAFLD) affects nearly one third of the population worldwide. Mexico is one of the countries whose population has several risk factors for the disease and its prevalence could surpass 50%. If immediate action is not taken to counteract what is now considered a national health problem, the medium-term panorama will be very bleak. This serious situation prompted the Asociacion Mexicana de Gastroenterologia and the Asociacion Mexicana de Hepatologia to produce the Mexican Consensus on Fatty Liver Disease. It is an up-to-date and detailed review of the epidemiology, pathaphysialogy, clinical forms, diagnosis, and treatment of the disease, whose aim is to provide the Mexican physician with a useful tool for the prevention and management of nonalcoholic fatty Liver disease. (C) 2019 Asociacion Mexicana de Gastroenterologia. Published by Masson Doyma Mexico S.A.

引用

页码：69 / 99

页数：31

共 297 条

[1] Effects of Mediterranean diet supplemented with silybin-vitamin E-phospholipid complex in overweight patients with non-alcoholic fatty liver disease [J].

Abenavoli, Ludovico ;

Greco, Marta ;

Nazionale, Immacolata ;

Peta, Valentina ;

Milic, Natasa ;

Accattato, Francesca ;

Foti, Daniela ;

Gulletta, Elio ;

Luzza, Francesco .

EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2015, 9 (04) :519-527

[2] Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases [J].

Adams, Leon A. ;

Anstee, Quentin M. ;

Tilg, Herbert ;

Targher, Giovanni .

GUT, 2017, 66 (06) :1138-1153

[3] NAFLD as a Risk Factor for the Development of Diabetes and the Metabolic Syndrome: An Eleven-Year Follow-up Study [J].

Adams, Leon A. ;

Waters, Oliver R. ;

Knuiman, Matthew W. ;

Elliott, Robert R. ;

Olynyk, John K. .

AMERICAN JOURNAL OF GASTROENTEROLOGY, 2009, 104 (04) :861-867

[4] Non-alcoholic fatty liver disease in 2015 [J].

Ahmed, Monjur .

WORLD JOURNAL OF HEPATOLOGY, 2015, 7 (11) :1450-1459

[5] Randomized, placebo-controlled trial of pioglitazone in nondiabetic subjects with nonalcoholic steatohepatitis [J].

Aithal, Guruprasad P. ;

Thomas, James A. ;

Kaye, Philip V. ;

Lawson, Adam ;

Ryder, Stephen D. ;

Spendlove, Ian ;

Austin, Andrew S. ;

Freeman, Jan G. ;

Morgan, Linda ;

Weeber, Jonathan .

GASTROENTEROLOGY, 2008, 135 (04) :1176-1184

[6] The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level Results From the Global Burden of Disease Study 2015 [J].

Akinyemiju, Tomi ;

Abera, Semaw ;

Ahmed, Muktar ;

Alam, Noore ;

Alemayohu, Mulubirhan Assefa ;

Allen, Christine ;

Al-Raddadi, Rajaa ;

Alvis-Guzman, Nelson ;

Amoako, Yaw ;

Artaman, Al ;

Ayele, Tadesse Awoke ;

Barac, Aleksandra ;

Bensenor, Isabela ;

Berhane, Adugnaw ;

Bhutta, Zulfiqar ;

Castillo-Rivas, Jacqueline ;

Chitheer, Abdulaal ;

Choi, Jee-Young ;

Cowie, Benjamin ;

Dandona, Lalit ;

Dandona, Rakhi ;

Dey, Subhojit ;

Dicker, Daniel ;

Phuc, Huyen ;

Ekwueme, Donatus U. ;

Zaki, Maysaa El Sayed ;

Fischer, Florian ;

Furst, Thomas ;

Hancock, Jamie ;

Hay, Simon I. ;

Hotez, Peter ;

Jee, Sun Ha ;

Kasaeian, Amir ;

Khader, Yousef ;

Khang, Young-Ho ;

Kumar, G. Anil ;

Kutz, Michael ;

Larson, Heidi ;

Lopez, Alan ;

Lunevicius, Raimundas ;

Malekzadeh, Reza ;

McAlinden, Colm ;

Meier, Toni ;

Mendoza, Walter ;

Mokdad, Ali ;

Moradi-Lakeh, Maziar ;

Nagel, Gabriele ;

Nguyen, Quyen ;

Nguyen, Grant ;

Ogbo, Felix .

JAMA ONCOLOGY, 2017, 3 (12) :1683-1691

[7] Cumulative risk of cardiovascular events after orthotopic liver transplantation [J].

Albeldawi, Mazen ;

Aggarwal, Ashish ;

Madhwal, Surabhi ;

Cywinski, Jacek ;

Lopez, Rocio ;

Eghtesad, Bijan ;

Zein, Nizar N. .

LIVER TRANSPLANTATION, 2012, 18 (03) :370-375

[8] Nonalcoholic fatty liver disease incidence and impact on metabolic burden and death: A 20 year-community study [J].

Allen, Alina M. ;

Therneau, Terry M. ;

Larson, Joseph J. ;

Coward, Alexandra ;

Somers, Virend K. ;

Kamath, Patrick S. .

HEPATOLOGY, 2018, 67 (05) :1726-1736

[9]

Aller R, 2014, EUR REV MED PHARMACO, V18, P1041

[10] The Prevalence of Non-Alcoholic Fatty Liver Disease in Children and Adolescents: A Systematic Review and Meta-Analysis [J].

Anderson, Emma L. ;

Howe, Laura D. ;

Jones, Hayley E. ;

Higgins, Julian P. T. ;

Lawlor, Debbie A. ;

Fraser, Abigail .

PLOS ONE, 2015, 10 (10)

← 1 2 3 4 5 6 7 8 9 10 →